Ireland has launched a new control programme aimed at Johne's disease on commercial farms, Agriland has reported. The programme targets a bacterial infection that cost the Irish dairy sector an estimated €15 million–€40 million per year in subclinical losses long before any animal shows outward signs of disease.

Johne's disease is caused by Mycobacterium avium subspecies paratuberculosis (MAP), a slow-growing pathogen that infects primarily cattle and other ruminants. Calves typically contract the organism through ingestion of contaminated milk, colostrum or faeces, then carry it for 2–10 years before developing the characteristic chronic diarrhoea, weight loss and reduced milk yield that mark the clinical stage.

Why this programme matters now

Subclinical infection is the economic problem. Herds with MAP circulation show lower milk yields, higher somatic cell counts, reduced fertility and culling rates that run several percentage points above MAP-negative comparables. Industry-level loss estimates for dairy systems cluster in the €200–€400 per infected cow per lactation range, depending on diagnostic definition and herd infection stage.

The pathogen also has a public-health dimension. MAP has been investigated as a possible contributor to Crohn's disease in humans; the link remains unestablished, but the uncertainty has pushed Johne's onto national control agendas across Europe.

What comparable programmes have done

Denmark has run a voluntary MAP programme since 2006 and reported herd-level prevalence falling from roughly 70% to below 10% in enrolled dairy herds over the following decade. The Netherlands operates a dairy-specific Johne's programme built around bulk milk ELISA screening, with positive herds moving to individual cow testing and management changes. France, Germany and several other EU member states run parallel schemes; none have declared MAP eradicated.

Across these efforts, the building blocks are consistent: herd-level risk assessment, ELISA-based screening of bulk milk or serum, faecal PCR confirmation of reactors, and segregation or culling of positive animals paired with calf-hygiene measures.

What the Irish announcement specifies

The Agriland report confirms a programme has been launched and frames it around Irish farms but does not detail funding mechanisms, mandatory versus voluntary herd participation, target prevalence or a defined end date. The reporting also does not specify which laboratories will run confirmatory testing, whether reimbursement will be available for producers, or how the new work will align with Ireland's existing TB and BVD eradication programmes run through Animal Health Ireland and the Department of Agriculture, Food and the Marine.

For practising veterinarians, the immediate questions are diagnostic: which ELISA platform the programme will endorse, how pools will be constructed for bulk milk testing, and how positive herd results will be communicated to producers without triggering unnecessary panic in low-prevalence holdings.

What happens next

Implementation guidance, including herd recruitment protocols and reimbursement structure, is expected to flow to farmers and veterinary practitioners through Teagasc, Animal Health Ireland and the Department of Agriculture, Food and the Marine in the months following the launch.